Evestia Clinical | Our Clinical Trial Expertise

Our Evolution

Evestia Clinical is charting a new course, building on a strong foundation to become a leading global clinical research organization.

Originally established in 1998 with a deep passion for advancing medical research, we’ve consistently focused on forging purposeful partnerships with our clients, characterized by genuine care and a shared dedication to achieving their goals. To better reflect who we are and better serve our biotech partners, we have strategically rebranded to Evestia Clinical.

This transition marks a clear vision for the future, solidifying our commitment to becoming a global leader in oncology and rare disease clinical trials.

Proven Expertise

At Evestia Clinical, we leverage our proven expertise to provide personalized service and strategic expansion, meeting the evolving needs of biotech innovators. Understanding the unique challenges these companies face, we act as your expert extension, deeply understanding your needs to deliver tailored, high-quality solutions with authentic expertise.

By capitalizing on our established capabilities and strategically investing in our infrastructure to support scaling and growth, we are a trusted partner for biotech companies, characterized by a high-touch, personalized approach. Through transparent communication and genuine partnership, we collaborate to accelerate your clinical ambitions and ultimately improve patient lives.

By fully understanding your unique needs, we craft solutions that are customized, meaningful, and impactful.

Learn About Our Experience

Leveraging Our Proven Expertise

At Evestia Clinical, we leverage our proven expertise to provide personalized service and strategic expansion, meeting the evolving needs of biotech innovators. Understanding the unique challenges these companies face, we act as your expert extension, deeply understanding your needs to deliver tailored, high-quality solutions with authentic expertise.

By capitalizing on our established capabilities and strategically investing in our infrastructure to support scaling and growth, we are a trusted partner for biotech companies, providing high-quality, tailored solutions characterized by a high-touch, personalized approach.

Through transparent communication and genuine partnership, we collaborate to accelerate your clinical ambitions and ultimately improve patient lives.

By fully understanding your unique needs, we craft solutions that are bespoke, meaningful, and impactful.

View Our Services

Key Milestones

Building Our Future

New Beginnings

In 2025, EMAS Pharma embraced a transformative shift, evolving into Evestia Clinical with a bold vision for global leadership in oncology and rare disease clinical trials, focused on advancing the future of healthcare.

Client Focus

A consistent theme throughout our journey has been our deep commitment to partnering with clients, striving to understand their ambitions and working collaboratively to achieve their goals.

Expert Team

As a client-focused partner, our strength lies in our deeply experienced team, bringing expert insights to complex trials, particularly within oncology and rare diseases. We are committed to your project’s success, working as a specialized extension of your team.

Our Commitment to Global Health

Driven by our vision to be the market-leading partner for biotechs and beyond, we aim to fuel medical breakthroughs and achieve a significant global health impact through strategic growth, supported by a fulfilling work environment.

View our Mission, vision and values